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Abstract
Background: Insulin-resistance is associated with cardiovascular disease but it is not used as a marker for disease
in clinical practice.
Aims: To study the association between the homeostatic model assessment (HOMA-IR) and triglyceride/HDLc ratio
(TG/HDLc) with the presence of coronary artery disease in patients submitted to cardiac catheterization.
Methods: In a cross-sectional study, 131 patients (57.0 ± 10 years-old, 51.5% men) underwent clinical, laboratory
and angiographic evaluation and were classified as No CAD (absence of coronary artery disease) or CAD (stenosis
of more than 30% in at least one major coronary artery).
Results: Prevalence of coronary artery disease was 56.7%. HOMA-IR and TG/HDLc index were higher in the CAD vs
No CAD group, respectively: HOMA-IR: 3.19 (1.70-5.62) vs. 2.33 (1.44-4.06), p = 0.015 and TG/HDLc: 3.20 (2.38-5.59)
vs. 2.80 (1.98-4.59) p = 0.045) - median (p25-75). After a ROC curve analysis, cut-off values were selected based on
the best positive predictive value for each variable: HOMA-IR = 6.0, TG/HDLc = 8.5 and [HOMA-IR×TG/HDLc] = 28.
Positive predictive value for coronary artery disease for HOMA-IR>6.0 was 82.6%, for TG/HDLc>8.5 was 85.7% and
for [HOMA-IR×TG/HDLc]>28 was 88.0%. Adjusted relative risk (age, gender, diabetes, body mass index, systolic
blood pressure) for the presence of coronary artery disease was: for HOMA-IR>6.0, 1.47 (95.CI: 1.06-2.04, p = 0.027),
for TG/HDLc>8.5, 1.46 (95% CI:1.07-1.98), p = 0.015) and for [HOMA-IR × TG/HDLc] >28, 1.64 (95%CI: 1.28-2.09), p <
0.001).
Conclusions: Increased HOMA-IR, TG/HDLc and their product are positively associated with angiographic coronary
artery disease, and may be useful for risk stratification as a high-specificity test for coronary artery disease.
Background
Insulin resistance is associated with cardiovascular dis-
ease [1]. Possible mechanisms include induction of pro-
inflammatory and pro-coagulant states which are detri-
mental to endothelial function and may play an impor-
tant role in mediating atherogenesis [2].
Homeostatic model assessment of insulin resistance
(HOMA-IR) has emerged as a practical and simple
method for estimating insulin resistance. This index was
extensively validated in comparison with the gold-stan-
dard method for the evaluation of insulin resistance, the
hyperinsulinemic euglycemic glucose clamp technique
[3]. While this method is currently not routinely used as
a cardiovascular risk marker, we hypothesized that it
could be potentially useful since hyperglycemia and
hyperinsulinemia are both related to cardiovascular dis-
ease. Also, since triglycerides and HDL are independent
predictors of cardiovascular risk [4], their ratio could be
used as a simple cardiovascular risk marker.
The aim of the present study was to study the associa-
tion between HOMA-IR and the triglyceride/HDLc ratio
with the presence of coronary artery disease in patients
who were submitted to coronary angiography and to
define the best cut-off values for clinical practical use.
Methods
This was a cross-sectional study with patients referred
for coronary angiography at a reference center for inter-
ventional cardiology. Between December 2002 and
December 2003, 150 patients were screened and 131,
who presented inclusion criteria and accepted to partici-
pate, were included. Inclusion criteria were age between
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clinical referral for coronary angiography by the attend-
ing physician. Exclusion criteria were: previous myocar-
dial infarction in the last 60 days, heart transplantation
or revascularization procedure, known malignant neo-
plasia, haemodialysis or current insulin therapy.
A clinical questionnaire, physical examination and a
12 h-fasting blood sample collection were performed on
all patients immediately before coronary angiography.
Each subject gave written consent and the study proto-
col was approved by the Hospital Ethics Committee.
Biochemical investigation
On the day of the procedure, a fasting blood sample was
obtained for glucose, total cholesterol, high-density cho-
lesterol (HDL-c), triglycerides (TG), creatinine, fibrino-
gen and ultrasensitive C-reactive protein (CRP).
Laboratory measurements were performed using auto-
mated enzymatic commercial kits (Roche, Mannheim,
GE). Fibrinogen was evaluated on a Fibrintimer II (Dade
Behring Inc, Newark, Marburg, Germany) and processed
in the auto-analyser (CA-540, Sysmex). The concentra-
tion of low-density cholesterol (LDL-c) was calculated
with Friedwald’s formula. Serum insulin was determined
by enzyme immunoassay commercial kits (Abbott-
Murex, Park, IL, USA) and CRP by nephelometry
(nephelometer BN100, Dade Behring Inc., Marburg,
Germany). Insulin resistance was assessed by the
HOMA-IR (homeostasis model assessment of insulin
resistance) method, as previously described [5].
Coronary angiography
Coronary angiographies were performed using Siemens
Axiom Artis equipment (Munich, Germany), and all
procedures followed standard routines. The coronary
angiograms were evaluated by two experienced interven-
tional cardiologists, unaware of the patients’ clinical pre-
sentation. Lesions quantification were performed using a
quantitative coronary angiography (QCA) software and
were stratified in mild (up 30% in lumen narrowing),
moderate (30 to 70% in lumen narrowing) or severe
(greater than 70% in lumen narrowing) disease. Angio-
graphic evidence of coronary artery disease was classi-
fied as: No CAD (complete absence of detectable
coronary artery disease) or CAD (30% or more stenosis
in at least one major coronary artery) to assure coronary
artery disease presence and avoid inclusion or misinter-
pretation of patients with incipient or very mild disease.
Statistical analysis
Continuous parametric variables such as age, body mass
index, systolic and diastolic blood pressure, LDLc, fibri-
nogen, HDLc, fasting plasma glucose and triglycerides/
HDLc ratio were analyzed using the Student t-test. Non-
parametrical variables, such as TG, TG/HDLc and
HOMA-IR were compared between groups by the
Mann-Whitney rank test and expressed as median (p25-
75). Categorical variables were compared by the Chi
square test. HOMA-IR was calculated using the follow-
ing formula [5]:
HOMA IR plasma insulin mUI L plasma glucose mg dl −= × × [( / ) [ (( / )       18 82 2 5 ]/ . .
I naR O Cc u r v ea n a l y s i s ,t h eb e s tp o s i t i v ep r e d i c t i v e
values for HOMA-IR, TG/HDLc and their product
(HOMA-IR×TG/HDLc) were defined as cut-off values
for the study. Relative risks were determined between
the presence or absence of coronary artery disease (out-
comes) vs A. HOMA-IR higher/equal vs. lower than the
cut-off level of 6.0, B. TG/HDLc index higher/equal vs.
lower than the cut-off level of 8.5 and C. The product
of HOMA-IR × TG/HDLc higher/equal vs. lower than
the cut-off level of 28 interval, using multivariate Pois-
son regression adjusted for age, sex diabetes, body mass
index and systolic blood pressure. For all tests a P value
≤ 0.05 was considered to be statistically significant.
Results
Clinical, biochemical and image data were available for all
131 patients. The mean age of the whole group was 57.8 ±
10.5 years and 51.5% were men. Clinical and laboratory
data are shown in Table 1. The percentage of patients
with coronary artery disease was 56.5% (CAD group). In
the CAD group patients were older, more frequently male
and there were slightly more cases of diabetes mellitus.
However, body mass index was lower in the CAD group,
as compared to those without coronary artery disease. No
differences were found regarding the frequency of arterial
hypertension, smoking or dyslipidemia.
TG/HDLc index and HOMA-IR were significantly
increased in the CAD group (Figure 1), as compared to
the No CAD group, (p = 0.0446 and p = 0.0152, respec-
tively). After a ROC curve analysis, the highest positive
predictive values were used as cut-off values. The cut-
off value for HOMA-IR was 6.0, for TG/HDLc index
was 8.5 and for the product [HOMA-IR × TG/HDLc]
was 28.0. The positive predictive value for the presence
of coronary artery disease with a HOMA-IR >6.0 was
82.6%, for a TG/HDLc > 8.5 was 85.7% and for
[HOMA-IR×TG/HDLc]>28 was 88.0% (Table 2).
In a multivariate regression, we determined the relative
risk for significant coronary artery disease (adjusted for
age, gender, body mass index, diabetes and systolic blood
pressure) for the variables HOMA-IR above 6.0, TG/
HDLc above 8.5 and [HOMA-IR×TG/HDLc] above 28.
All variables were associated to significantly increased
relative risk for coronary artery disease (Table 3, model
A). In order to remove an eventual effect of oral anti-dia-
betic agents in HOMA-IR, data were re-analyzed without
the patients on these medications (n = 14) and relative
risks remained significantly increased (Table 3, model B).
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Age (years) 55.3 ± 10.0 60.3 ± 10.5 0.006
Male (%) 20 (33.9) 49 (64.5) < 0.001
BMI (kg/m
2) 29.8 ± 5.5 27.0 ± 4.4 0.002
Systolic BP (mmHg) 140.4 ± 26.6 140.1 ± 22.4 0.950
Diastolic BP (mmHg) 86.3 ± 17.2 84.3 ± 12.1 0.450
Diabetes Mellitus (%) 15 (25.8) 36 (48.6) 0.005
Arterial Hypertension (%) 40 (68.9) 52 (72.2) 0.650
Smokers (%) 12 (20.3) 25 (34.7) 0.069
Statin users (%) 9 ( 15.2) 15 ( 19.7) 0.499
Oral anti-diabetic agents (%) 5 (8.8) 9 (12.1) 0.482
Physically active (% of total) 12 (20.6 ) 25 ( 32.9 ) 0.114
HbA1c (%) 5.9 ± 0.9 6.2 ± 1.1 0.180
Fasting plasma glucose (mg/dl) 101.1 ± 33.3 117.7 ± 48.7 0.027
LDLc (mg/dl) 117.2 ± 33.1 121.1 ± 37.3 0.064
HDLc (mg/dl) 49.8 ± 11.7 45.7 ± 10.5 0.036
Triglycerides (mg/dl) 143.0 (95.0-208.0) 170.0 (106.7-219.5) 0.134
C-Reactive Protein (mg/dl) 3.04 ± 2.05 3.24 ± 2.25 0.636
Serum creatinine (mg/dl) 0.96 ± 0.22 1.08 ± 0.35 0.029
Fibrinogen (mg/dl) 336.9 ± 81.2 357.6 ± 97.3 0.488
Data expressed as mean and standard deviation or n (%), except for triglycerides, which is presented as median and p25-p75 range. CAD = coronary artery
disease group, No CAD = absence of coronary disease group, BMI = body mass index; BP = Blood pressure; LDL-c = low-density lipoprotein cholesterol; HDLc=
high-density lipoprotein; HbA1c = Glycated hemoglobin. Physically active individuals were defined as those who performed at least 150 min of moderate/intense
exercise per week.
Figure 1 Triglycerides/HDLc ratio (A) and HOMA-IR (B) in patients with any coronary lesion (CAD, n = 74) or without coronary artery
disease (No CAD n = 57). Data are median and p25-p75. *P < 0.005.
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In the present study, we showed an association between
insulin resistance, with the presence of coronary artery
disease in patients referred for coronary angiography. A
HOMA-IR higher than 6.0 and the TG/HDLc index above
8.5 were associated with the presence of coronary lesions,
and it was independent of age, gender, body mass index,
diabetes mellitus and systolic blood pressure. This effect
w a su n l i k e l yt ob ed u et ot h eu s eo fa n t i - d i a b e t i co r a l
agents on HOMA-IR because patients on these medica-
tions were removed from the analysis and the results did
not change. The product of HOMA-IR and TG/HDLc
index had an even stronger association with the presence
of coronary artery disease than each variable alone. Con-
sidering that these patients were in intermediate-high risk
for coronary artery disease, these tests presented a very
high positive predictive value.
Insulin resistance evaluated by the HOMA-IR and tri-
glyceride measurements is usually not included in the
recommendations for cardiovascular risk stratification
[6]. These conditions are generally considered emerging
risk factors [7], although two meta-analyses have shown
predictive value for cardiovascular outcomes [8,9]. How-
ever, we did not find studies using both HOMA-IR and
TG/HDLc, as a risk factor.
Although cause-effect conclusions cannot be drawn
from cross-sectional studies, the associations observed
in the present study raises the hypothesis that these
measurements, used together, may optimize stratifica-
tion of coronary artery disease risk. This is in accor-
dance with prospective studies showing that insulin
resistance, as evaluated by HOMA-IR [10] or by the
euglycemic hyperinsulinemic clamp [11], indicates that
it is associated with the occurrence of major cardiovas-
cular events and coronary heart disease. In one study,
increased HOMA-IR was associated with an increased
incidence of myocardial infarction and death, even when
the cardiovascular risk was adjusted for smoking and
low physical activity. Interestingly, in that study, insulin
resistance was defined in those subjects who present
HOMA-IR in the 75
th percentile (1.80 for women and
2.12 for men), a much lower threshold than used in the
present study [12].
Hyperinsulinemia was shown to be an independent pre-
dictor of complex atherosclerotic lesions detected by echo-
cardiography in the thoracic aorta in non-diabetic patients
[13]. Previous studies have investigated the association
between angiographically proven coronary atherosclerosis
and insulin resistance evaluated by a HOMA-IR higher
than 1.8 (the median value). Patients with higher levels of
insulin resistance had a more severe, extensive, and distal
type of coronary artery disease [14].








2.0 71.6 45.6 63.1
3.0 56.7 59.6 64.6
4.0 45.9 73.7 69.4
5.0 32.4 84.2 72.7
5.5 29.7 89.5 78.6
6.0 25.7 92.9 82.6
7.0 20.2 92.9 78.9
TG/HDLc
2.0 85.1 24.1 58.8
3.0 59.4 53.4 62.0
4.0 47.3 68.9 66.0
5.0 32.4 81.0 68.6
6.0 20.2 86.2 65.2
7.0 16.2 93.0 75.0
8.0 16.2 94.8 80.0
8,5 16.2 96.5 85.7
HOMA-IR × TG/HDLc
4 (p25) 80.8 29.8 59.6
10 (p50) 57.5 59.6 64.6
24 (p75) 34.2 85.9 75.7
28 (p80) 30.1 94.7 88.0
Sensitivity, specificity, positive predictive value (PPV), for different cut-off
values of homeostatic model assessment (HOMA-IR), Triglyceride/HDLc index
(TG/HDLc) and the product [HOMA-IR×TG/HDLc].
Table 3 Multivariate regression analysis and relative risks for coronary artery disease for HOMA-IR > 6, TG/HDLc index
> 8.5 and [HOMA-IR × TG/HDLc] > 28 with adjustments.
Model A RR 95% CI p adjustments
HOMA IR >6.0 1.178 1.043-1.330 0.008 age, BMI, gender, diabetes, SBP
TG/HDLc >8.5 1.175 1.040.1.330 0.043 age, BMI, diabetes, SBP, gender
[HOMA-IR×TG/HDLc]>28 1.220 1.125-1347 <0.001 age, BMI, diabetes, SBP, gender
Model B RR 95% CI p adjustments
HOMA IR >6.0 1.161 1.016-1.326 0.028 age, BMI, diabetes, SBP
TG/HDLc >8.5 1.158 1.005-1.335 0.043 age, BMI, diabetes, SBP, gender
[HOMA-IR×TG/HDLc]>28 1.231 1.125-1347 < 0.001 age, BMI, diabetes, SBP, gender
Model A refers to all patients of the study, n = 131. Model B refers to patients without oral anti-diabetic agents (n = 117).
BMI = Body mass index. SBP = Systolic blood pressure. RR = Relative risk. P value was obtained after adjustments.
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to be associated with ischemic heart disease. In a pre-
vious cohort study, asymptomatic men initially free
from ischemic heart disease who presented eletrocardio-
graphic changes after 8 years, had more fatal acute myo-
cardial infarction when increased TG/HDLc was also
present, indicating a synergistic effect of both low HDLc
and high triglyceride levels [15].
A potential limitation of the present study is that sub-
clinical or mild disease could be better assessed using
intravascular ultrasound or optical coherence tomogra-
phy. Also, LDL cholesterol levels, used in most studies
and ascertained as classic risk factor for coronary artery
disease, are actually estimations calculated with the
same variables as in the TG/HDLc relationship with the
exception of total cholesterol. Thus, considerable corre-
lation between both values is expected. However, a com-
parison of TG/HDLc with LDL cholesterol levels is
beyond the scope of the present study.
We believe that this simple and non-invasive set of
tests may be a useful tool in optimizing the selection of
patients to proceed to a more invasive investigation.
Further longitudinal studies on insulin resistance and
coronary artery disease should be undertaken in order
to confirm these data in high-risk patients.
Conclusions
We conclude that because increased HOMA-IR, TG/
HDLc and their product are positively associated with
the angiographic coronary artery disease, they may be
useful for cardiovascular risk stratification.
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